CDC deputy director Jennifer Shuford will leave Nov. 12 after four months, citing family while a former official claims she hit a red line.
The Hill reported that Dr. Jennifer Shuford, deputy director and chief medical officer at the Centers for Disease Control and Prevention, is exiting the agency after a brief tenure that began with her April appointment.
Her last day is set for Nov. 12. She is staying on just past the midterm elections. Career official Satish Pillai will serve as acting deputy director and chief medical officer while the CDC seeks a permanent successor.
Shuford framed the move in plain terms. She said she is leaving to spend more time with her family and thanked the officials who put her in the post.
"I am leaving to spend more time with my family. I am so thankful to President Trump and Secretary Kennedy for giving me the opportunity to help lead CDC. It has been an amazing experience and I will be forever grateful for it,"
CDC Director Erica Schwartz issued a statement praising the outgoing chief medical officer’s work under pressure.
"I am deeply grateful for Dr. Shuford’s outstanding leadership and commitment to CDC and public health, especially as she has navigated an exceptionally demanding, high-profile, and constantly evolving environment over the past several months,"
Shuford arrived in April as part of a leadership team built to support Schwartz. Sean Slovenski was named chief operating officer in the same wave. That team was hired to steady an agency that had taken heavy hits to public trust.
Short tenures in high-stakes posts are not new in this administration, a pattern also seen when Katie Zacharia exited the White House press secretary role after only days on the job.
Before the CDC post, Shuford served as Texas health commissioner. There she coordinated the state’s response to a measles outbreak. Career CDC staff respected that record. At the CDC she helped lead the agency’s response to an Ebola outbreak in Africa and took part in the decision to quarantine overseas Americans exposed to the virus rather than bring them home right away. As chief medical officer she also would have been directly involved in how the agency defines a measles death.
The CDC has faced criticism over a spreading measles outbreak and a dispute with Pennsylvania over whether several deaths should be counted as measles-related. Shuford’s portfolio put her near those fights.
Just the News reported that objections to the administration’s vaccine policy factored into her exit, citing Washington Post sources. Shuford’s own statement did not mention vaccines. She stuck to family and gratitude.
Dr. Demetre Daskalakis, who resigned from the CDC in protest in August 2025, offered a sharper reading in a text message to The Hill.
"I imagine that she has found her red line,"
He added a second judgment on the same thread.
"She is an excellent public health leader. I fear what is to come next."
Those lines come from an official who already quit in protest. They are speculation, not a personnel file. Shuford thanked President Trump and Secretary Kennedy on her way out the door. That is the record she left in public.
Personnel movement has marked other corners of the executive branch as well, including the moment James Braid left his post as legislative director in the weeks before the midterms.
The CDC said it will “initiate the process of identifying a permanent successor in the near future.” Pillai, a career public health official, holds the acting role in the meantime. Continuity does not freeze because one appointee goes home.
April to mid-November is a short run for a deputy director and chief medical officer. The files on her desk were not light: measles definitions, an overseas Ebola response, quarantine calls, and an agency still arguing with states over death counts. She leaves with a public thank-you to the president and the secretary who installed her, and with her director on the record calling the work outstanding.
Other recent exits have drawn their own headlines, from Katie Zacharia’s exit after less than a week to broader staffing shifts elsewhere in the West Wing.
The agency now turns to a permanent search. Acting leadership is already named. Shuford’s stated reason remains family. Critics who left earlier are free to imagine red lines. Voters and patients will judge the next chief medical officer by results on outbreaks, definitions, and basic competence, not by exit interviews from officials who already walked away.
Turnover stories keep coming, a point underscored when Trump moved White House counsel Samuel Adkisson toward a federal bench seat amid a wider run of staff changes.
Public health posts demand long hours and hard calls. When an appointee says the family clock has run out, that answer should be taken at face value unless hard evidence says otherwise. Protest alumni will always predict collapse. The job is to keep the agency honest, lawful, and focused on disease control under the officials voters actually elected.
